Survival benefits of metformin for colorectal cancer patients with diabetes: A systematic review and meta-analysis

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Mei, Zu Bing ^a   Zhang, Zhi Jiang ^b   Liu, Chen Ying ^a   Liu, Yun ^a   Cui, Ang ^a   Liang, Zhong Lin ^a   Wang, Guang Hui ^a   Cui, Long ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

METFORMIN;

ARTICLE; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; COHORT ANALYSIS; COLORECTAL CANCER; DIABETES MELLITUS; DRUG EXPOSURE; HUMAN; META ANALYSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROGNOSIS; RISK ASSESSMENT; COLORECTAL NEOPLASMS; COMPLICATION; DIABETES MELLITUS, TYPE 2; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; PUBLISHING; SURVIVAL;

COLORECTAL NEOPLASMS; DIABETES MELLITUS, TYPE 2; HUMANS; METFORMIN; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; PUBLICATION BIAS; SURVIVAL ANALYSIS;

EID: 84898603942     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0091818     Document Type: Article

References (31)

1. Adami H-O, McLaughlin J, Ekbom A, Berne C, Silverman D, et al. (1991) Cancer risk in patients with diabetes mellitus. Cancer Causes Control 2: 307-314.
2. La Vecchia C, Negri E, Franceschi S, D'avanzo B, Boyle P (1994) A case-control study of diabetes mellitus and cancer risk. Brit J Cancer 70: 950.
3. Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, et al. (2010) Diabetes and cancer: a consensus report. Ca-Cancer J Clin 60: 207-221.
4. Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ (2004) Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. A J Epidemiol 159: 1160-1167. (Pubitemid 38747263)
5. Rousseau MC, Parent MÉ, Pollak MN, Siemiatycki J (2006) Diabetes mellitus and cancer risk in a population-based case-controlstudy among men from Montreal, Canada. Int J Cancer 118: 2105-2109.
6. Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M, et al. (2006) Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med 166: 1871.
7. He X, Esteva F, Ensor J, Hortobagyi G, Lee M-H, et al. (2012) Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer. Ann Oncol 23: 1771-1780.
8. He X-X, Tu S, Lee M-H, Yeung S-C (2011) Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients. Ann Oncol 22: 2640-2645.
9. Boyd DB. (2003) Insulin and cancer. Integ Cancer Ther 2: 315-329.
10. Barone BB, Yeh H-C, Snyder CF, Peairs KS, Stein KB, et al. (2008) Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus. JAMA-J Am Med Assc300: 2754-2764.
11. Zhang Z-J, Zheng Z-J, Kan H, Song Y, Cui W, et al. (2011) Reduced Risk of Colorectal Cancer With Metformin Therapy in Patients With Type 2 Diabetes A meta-analysis. Diabetes Care 34: 2323-2328.
12. Lee M-S, Hsu C-C, Wahlqvist M, Tsai H-N, Chang Y-H, et al. (2011) Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals. BMC cancer 11: 20.
13. Del Barco S, Vazquez-Martin A, Cufí S, Oliveras-Ferraros C, Bosch-Barrera J, et al. (2011) Metformin: multi-faceted protection against cancer. Oncotarget 2: 896.
14. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, et al. (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Prev Med 45: 247-251. (Pubitemid 47562537)
15. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Controlled clinical trials 7: 177-188. (Pubitemid 17189972)
16. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. Brit Med J 327: 557.
17. Duval S, Tweedie R (2000) Trim and Fill: A Simple Funnel-Plot-Based Method of Testing and Adjusting for Publication Bias in Meta-Analysis. Biometrics 56: 455-463. (Pubitemid 30422636)
18. Cossor FI, Adams-Campbell LL, Chlebowski RT, Gunter MJ, Johnson K, et al. (2013) Diabetes, metformin use, and colorectal cancer survival in postmenopausal women. Cancer Epidemiol.
19. Lee JH, Kim TI, Jeon SM, Hong SP, Cheon JH, et al. (2012) The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus. Int J Cancer 131: 752-759.
20. Garrett CR, Hassabo HM, Bhadkamkar NA, Wen S, Baladandayuthapani V, et al. (2012) Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer. Brit J Cancer 106: 1374-1378.
21. Spillane SC, Bennett K, Sharp L, Barron TI (2013) A cohort study of metformin exposure and survival in patients with stage I-III colorectal cancer. Cancer Epidem Biomar.
22. Lee GE, Aung T, Lim KH, Tan WS, Tai WMD, et al. (2012) Examining the effects of metformin on survival outcome in stage II/III colorectal cancer patients with diabetes mellitus. J Clin Oncol 30.
23. Bansal M, Siegel E, Govindarajan R (2011) The effect of metformin (M) on overall survival (OS) of patients (Pts) with colorectal cancer (CRC) treated with chemotherapy (CTX). ASCO Meeting Abstracts 29: 2608.
24. von Elm E, Altman D, Egger M, Pocock S, Gøtzsche P, et al. (2007) the STROBE Initiative and the STROBE Initiative Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 3709596: 1453-1457.
25. Larsson SC, Orsini N, Wolk A (2005) Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Nati Cancer I 97: 1679-1687. (Pubitemid 41672234)
26. Yang Y-X, Hennessy S, Lewis JD (2005) Type 2 diabetes mellitus and the risk of colorectal cancer. Clin Gastroenterol H 3: 587-594. (Pubitemid 40824752)
27. Yang YX, Hennessy S, Lewis JD (2004) Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients. Gastroenterology 127: 1044-1050. (Pubitemid 39345873)
28. Libby G, Donnelly LA, Donnan PT, Alessi DR, Morris AD, et al. (2009) New Users of Metformin Are at Low Risk of Incident Cancer A cohort study among people with type 2 diabetes. Diabetes Care 32: 1620-1625.
29. Currie C, Poole C, Gale E (2009) The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia 52: 1766-1777.
30. Sahra IB, Le Marchand-Brustel Y, Tanti J-F, Bost F (2010) Metformin in cancer therapy: a new perspective for an old antidiabetic drug? Mol Cancer Ther 9: 1092-1099.
31. Hill AB (1965) The environment and disease: association or causation? P R Soc Med 58: 295.